5-BPDi

5-BPDi (Indanyl-α-PHP) is a substituted cathinone first reported in 2015. It is structurally related to α-PHP with an indane ring replacing the phenyl ring. No pharmacological, toxicological, or human safety data exist. No reliable user reports or dosage information are available.

Also known as: Indanyl-α-php, 3',4'-trimethylene-α-pyrrolidinohexanophenone, Indanyl-alpha-PHP

Classification

Chemical: Cathinone
Psychoactive: Stimulant
Tag: Habit-Forming
Tag: Pyrrolidinophenone
Tag: Research-Chemical
Tag: Tentative

Effects

Physical Energy
Loss Of Appetite
Teeth Grinding
Jaw Tension
Insomnia
Itching
Euphoria
Increased Focus
Anxiety
Agitation
Paranoia
Hypervigilance
Light Sensitivity
Appetite Suppression
Increased Libido
Disinhibition
Tactile Enhancement
Dehydration

Routes of Administration

Oral

Dosage

Common: 10-25 mg
Heavy: 45 mg+
Light: 7.5-10 mg
Strong: 25-45 mg
Threshold: 5 mg

Duration

Onset: 0.25-0.5 h
Peak: 1-3 h
Offset: 3-5 h
After Effects: 5-16 h
Total Duration: 4-8 h

Insufflated

Dosage

Heavy: 35 mg+
Light: 5–8 mg
Common: 8–20 mg
Strong: 20–35 mg
Threshold: 3 mg

Duration

Onset: 0.08-0.17 h
Peak: 0.5-2 h
Offset: 2-3.5 h
After Effects: 3.5-24 h
Total Duration: 2-5 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu